Is this you? Create Your Porfile
Avatar

Christian J. Wiedermann

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Christian J. Wiedermann is active.

Explore More

Publication

Featured researches published by Christian J. Wiedermann.

Archive | 2013

USE IN BRAIN DEGENERATIVE DISEASES

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Use of Sphingosine-1-Phosphate (S1P) Receptor Agonists For the Treatment of Brain Degenerative Diseases

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2013

Blood-Derived Dendritic Cells Attract Immature and Arrest Mature Cutting Edge: Peripheral Neuropeptides

Herbert Tilg; Christian J. Wiedermann; Stefan Dunzendorfer; Arthur Kaser; Christian Meierhofer

Archive | 2011

脳変性疾患の処置のためのスフィンゴシン−１−ホスフェート（ｓ１ｐ）受容体アゴニストの使用

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann; クリスティアン・イェー・ヴィーダーマン; ニコーレ・カナイダー; フォルカー・ブリンクマン

Archive | 2011

Use of sphingosine-1-phosphate(s1p) receptor agonist for treatment of cerebral degeneration disorder

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann; クリスティアン・イェー・ヴィーダーマン; ニコーレ・カナイダー; フォルカー・ブリンクマン

Archive | 2010

Th1 induction by DC2s through IL-18 receptor expression Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes

Herbert Tilg; Arthur Kaser; Susanne Kaser; Nicole Kaneider; Barbara Enrich; Christian J. Wiedermann

Archive | 2004

Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Utilisation d'agonistes du recepteur de sphingosine-1-phosphate pour le traitement de maladies degeneratives des fonctions cerebrales

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Verwendung von sphingosin-1-phosphat (s1p) rezeptor-agonisten zur behandlung von degenerativen gehirnerkrankungen Use of sphingosine 1-phosphate (S1P) receptor agonist for the treatment of degenerative brain disorders

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Uso de agonistas de receptores de 1-fosfato de esfingosina (s1p) para el tratamiento de enfermedades cerebrales degenerativas.

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Explore More

Collaboration

Dive into the Christian J. Wiedermann's collaboration.

Top Co-Authors
Avatar

Volker Brinkmann

Novartis

View shared research outputs
Top Co-Authors
Avatar

Nicole Kaneider

Novartis

View shared research outputs
Top Co-Authors
Avatar

Nicole Kaneider

Novartis

View shared research outputs
Top Co-Authors
Avatar

Herbert Tilg

Tufts University

View shared research outputs
Top Co-Authors
Avatar

Arthur Kaser

University of Innsbruck

View shared research outputs
Top Co-Authors
Avatar

Barbara Enrich

Innsbruck Medical University

View shared research outputs
Top Co-Authors
Avatar

Christian Meierhofer

University of Innsbruck

View shared research outputs
Top Co-Authors
Avatar

Stefan Dunzendorfer

Innsbruck Medical University

View shared research outputs
Top Co-Authors
Avatar

Susanne Kaser

Innsbruck Medical University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge